YAP1 and invasive breast carcinoma: The fact that the entire data set is from invasive breast cancers negates direct mSigDB analysis in different groups; however, we could control for the increased invasive transcripts in the pS127-YAP1low group as neither the YAP-TAZ or an unrelated signature displayed variation (Figures 7A and S7A; Table S1).